Role of Calcitonin gene-related peptide in bone repair after cyclic fatigue loading

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Sample, Susannah J ^a   Hao, Zhengling ^a   Wilson, Aliya P ^a   Muir, Peter ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN GENE RELATED PEPTIDE[8-37]; SODIUM CHLORIDE; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG; ACID PHOSPHATASE; CALCEIN; CALCITONIN GENE RELATED PEPTIDE (8 37); CALCITONIN GENE-RELATED PEPTIDE (8-37); FLUORESCEIN DERIVATIVE; ISOENZYME; PEPTIDE FRAGMENT; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE INJURY; BONE REMODELING; BONE STRESS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; MALE; NONHUMAN; OSSIFICATION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; ULNA; WEIGHT BEARING; ANIMAL; BLOOD; BONE DEVELOPMENT; DRUG EFFECT; MECHANICAL STRESS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WOUND HEALING;

RATTUS;

ACID PHOSPHATASE; ANIMALS; BONE REMODELING; CALCITONIN GENE-RELATED PEPTIDE; FLUORESCEINS; ISOENZYMES; MALE; OSTEOGENESIS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; STRESS, MECHANICAL; ULNA; WEIGHT-BEARING; WOUND HEALING;

EID: 79958263329     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020386     Document Type: Article

References (63)

1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, et al. (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22: 465-467.
2. Burr DB, Forwood MR, Fyhrie DP, Martin RB, Schaffler MB, et al. (1997) Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 12: 6-15.
3. Muir P, Johnson KA, Ruaux-Mason C, (1999) In vivo matrix microdamage in a naturally occurring canine fatigue fracture. Bone 25: 571-576.
4. Muir P, McCarthy J, Radtke CL, Markel MD, Santschi EM, et al. (2006) Role of endochondral ossification of articular cartilage and adaptation of the subchondral plate in the development of fatigue microcracking of joints. Bone 38: 342-349.
5. Frost HM, (2001) From Wolff's Law to the Utah Paradigm: Insights about bone physiology and its clinical applications. Anat Rec 262: 398-419.
6. Burr DB, (2002) Targeted and nontargeted remodeling. Bone 30: 2-4.
7. Chenu C, (2004) Role of innervation in the control of bone remodeling. J Musculoskel Neuron Interact 4: 132-134.
8. Robling AG, Castillo AB, Turner CH, (2006) Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng 8: 455-498.
9. Sample SJ, Behan M, Smith L, Oldenhoff WE, Markel MD, et al. (2008) Functional adaptation to loading of a single bone is neuronally regulated and involves multiple bones. J Bone Miner Res 23: 1372-1381.
10. Wu Q, Sample SJ, Baker TA, Thomas CF, Behan M, et al. (2009) Mechanical loading of a long bone induces plasticity in sensory input to the central nervous system. Neurosci Lett 463: 254-257.
11. Elefteriou F, (2008) Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 473: 231-236.
12. Martin CD, Jimenez-Andrade JM, Ghilardi JR, Mantyh P, (2007) Organization of a unique net-like meshwork of CGRP+ sensory fibers in the mouse periosteum: Implications for the generation and maintenance of bone fracture pain. Neurosci Lett 427: 148-152.
13. Hill EL, Elde R, (1991) Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res 264: 469-480.
14. Hukkanen M, Konttinen YT, Rees RG, Gibson SJ, Santavirta S, et al. (1992) Innervation of bone from healthy and arthritic rats by substance P and calcitonin gene related peptide containing sensory fibers. J Rheumatol 19: 1252-1259.
15. Tabarowski Z, Gibson-Berry K, Felten SY, (1996) Noradrenergic and peptidergic innervation of the mouse femur bone marrow. Acta Histochem 98: 453-457.
16. Hohmann EL, Elde RP, Rysavy JA, Einzig S, Gebhard RL, (1986) Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 232: 868-871.
17. Konttinen Y, Imai S, Suda A, (1996) Neuropeptides and the puzzle of bone remodeling. State of the art. Acta Orthop Scand 67: 632-639.
18. Imai S, Rauvala H, Konttinen YT, Tokunaga T, Maeda T, et al. (1997) Efferent targets of osseous CGRP-immunoreactive nerve fiber before and after bone destruction in adjuvant arthritic rat: An ultramorphological study on their terminal-target relations. J Bone Miner Res 12: 1018-1027.
19. Spencer GJ, Hitchcock IS, Genever PG, (2004) Emerging neuroskeletal signaling pathways: a review. FEBS Lett 559: 6-12.
20. Naot D, Cornish J, (2008) The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone 43: 813-818.
21. Mrak E, Guidobono F, Moro G, Fraschini G, Rinacci A, et al. (2010) Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by β-catenin stabilization. J Physiol 225: 701-708.
22. Lerner UH, (2002) Neuropeptidergic regulation of bone resorption and bone formation. J Musculoskel Neuron Interact 2: 440-447.
23. Hay DL, (2007) What makes a CGRP2 receptor? Clin Exp Pharmacol Physiol 34: 963-971.
24. Lerner UH, Persson E, (2008) Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. J Musculoskelet Neuronal Interact 8: 154-165.
25. Owan I, Ibaraki K, (1994) The role of calcitonin gene-related peptide (CGRP) in macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cells. Bone Miner 24: 151-164.
26. Zaidi M, Chambers TJ, Gaines Das RE, Morris HR, MacIntyre I, (1987) A direct action of human calcitonin gene-related peptide on isolated osteoclasts. J Endocrinol 115: 511-518.
27. Villa I, Dal Fiume C, Maestroni A, Rubinacci A, Ravasi F, et al. (2003) Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. Am J Physiol Endocrinol Metab 284: E627-633.
28. Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, et al. (1985) Expression in brain of messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229: 1094-1097.
29. Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, et al. (1999) Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res 14: 1302-1309.
30. Valentijn K, Gutow AP, Troiano N, Gundberg C, Gilligan JP, et al. (1997) Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats. Bone 21: 269-274.
31. Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, et al. (1999) Targeted expression of calcitonin gene related peptide to osteoblasts increases bone density in mice. J Bone Miner Res 14: 1067-1074.
32. Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, et al. (2004) Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner Res 19: 2049-2056.
33. Hirt D, Bernard GW, (1997) CGRP-beta unlike CGRP-alpha has no osteogenic stimulatory effect in vitro. Peptides 18: 1461-1463.
34. Uzan B, Villemin A, Garel JM, Cressent M, (2007) Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway. J Cell Physiol 215: 122-128.
35. Gangula PR, Wimalawansa SJ, Yallampalli C, (2002) Sex steroid hormones enhance hypotensive effects of calcitonin gene-related peptide in aged female rats. Biol Reprod 67: 1881-1887.
36. Reinshagen M, Flämig G, Ernst S, Geerling I, Wong H, et al. (1998) Calcitonin gene-related peptide mediates the protective effect of sensory nerves in a model of colonic injury. J Pharmacol Exp Ther 286: 657-661.
37. Kotha SP, Hsieh YF, Strigel RM, Müller R, Silva MJ, (2004) Experimental and finite element analysis of the rat ulnar loading model - correlations between strain and bone formation following fatigue loading. J Biomech 37: 541-548.
38. de Souza RL, Pitsillides AA, Lanyon LE, Skerry TM, Chenu C, (2005) Sympathetic nervous system does not mediate the load-induced cortical new bone formation. J Bone Miner Res 20: 2159-2168.
39. Irie K, Hara-Irie F, Ozawa H, Yajima T, (2002) Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech 58: 85-90.
40. Li J, Kreicbergs A, Bergström J, Stark A, Ahmed M, (2007) Site-specific CGRP innervation coincides with bone formation during fracture healing and modeling: a study in rat angulated tibia. J Orthop Res 25: 1204-1212.
41. Boyce BF, Xing L, (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473: 139-146.
42. Henriksen K, Tanko LB, Qvist P, Delmas PD, Christiansen C, et al. (2007) Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases. Osteoporosis Int 18: 681-685.
43. Sample SJ, Behan M, Collins RJ, Wilson AP, Markel MD, et al. (2010) Systemic effects of ulna loading in young male rats during functional adaptation. J Bone Miner Res 25: 2016-2028.
44. Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, et al. (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113: 155-166.
45. Ivanusic JJ, (2009) Size, neurochemistry, and segmental distribution of sensory neurons innervating the rat tibia. J Comp Neurol 517: 276-283.
46. Drissi H, Hott M, Marie PJ, Lasmoles F, (1997) Expression of the CT/CGRP gene and its regulation by dibutyryl cyclic adenosine monophosphate in human osteoblastic cells. J Bone Miner Res 12: 1805-1814.
47. Muir P, Sample SJ, Barrett JG, McCarthy J, Vanderby R Jr, et al. (2007) Effect of fatigue loading and associated matrix microdamage on bone blood flow and interstitial fluid flow. Bone 40: 948-956.
48. Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, et al. (2010) Calcitonin-gene related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-κB activation, osteoclastogenesis and bone resorption. Bone 46: 1369-1379.
49. Bernard GW, Shih C, (1990) The osteogenic stimulating effect of neuroactive calcitonin gene-related peptide. Peptides 11: 625-632.
50. Yu LC, Hou JF, Fu FH, Zhang YX, (2009) Roles of calcitonin gene-related peptide and its receptors in pain-related behavioral responses in the central nervous system. Neurosci Biobehav Rev 33: 1185-1191.
51. Tilakaratne N, Christopoulos G, Zumpe ET, Foord SM, Sexton PM, (2000) Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependant upon receptor isoform and host cell environment. J Pharmacol Exp Ther 294: 61-72.
52. Hay DL, Christopoulos G, Christopoulos A, Poyner DR, Sexton PM, (2005) Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes. Mol Pharmacol 67: 1655-1665.
53. Han SP, Naes L, Westfall TC, (1990) Calcitonin gene-related peptide is the endogenous mediator of nonadrenergic-noncholinergic vasodilation in rat mesentery. J Pharmacol Exp Ther 255: 423-428.
54. Haegerstrand A, Dalsgaard CJ, Jonzon B, Larsson O, Nilsson J, (1990) Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 87: 3299-3303.
55. Greenburg B, Rhoden K, Barnes P, (1987) Calcitonin gene-related peptide (CGRP) is a potent non-endothelium-dependent inhibitor of coronary vasomotor tone. Br J Pharmac 92: 789-794.
56. Gangula PR, Zhao H, Supowit SC, Wimalawansa SJ, Dipette DJ, et al. (2000) Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension 35: 470-475.
57. Kubota M, Moseley JM, Butera L, Dusting GJ, MacDonald PS, et al. (1985) Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun 132: 88-94.
58. Gross TS, Damji AA, Judex S, Bray RC, Zernicke RF, (1999) Bone hyperemia precedes disuse-induced intracortical bone resorption. J Appl Physiol 86: 230-235.
59. Wimalawansa SJ, (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology and therapeutic potentials. Endocr Rev 17: 533-585.
60. Kelly PJ, Bronk JT, (1990) Venous pressure and bone formation. Microvasc Res 39: 364-375.
61. Bergula AP, Huang W, Frangos JA, (1999) Femoral vein ligation increases bone mass in the hindlimb suspended rat. Bone 24: 171-177.
62. Ishizuka K, Hirukawa K, Nakamura H, Togari A, (2005) Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Neurosci Lett 379: 47-51.
63. Yoneda T, Hata K, Nakanishi M, Nagae M, Nagayama T, et al. (2011) Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone 48: 100-105.